Inventor
SLUSHER BARBARA S
US52 patents
⚠️ This page may combine multiple inventors who share the name “SLUSHER BARBARA S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GUILFORD PHARM INC
44 patentsUS5968915AOct 19, 1999
Naaladase inhibitors
GUILFORD PHARM INC102 citations99
US6384022B1May 7, 2002
Prodrugs of NAALAdase inhibitors
GUILFORD PHARM INC82 citations98
US6017903AJan 25, 2000
Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
GUILFORD PHARM INC88 citations98
US5962521AOct 5, 1999
Hydroxamic acid derivatives
GUILFORD PHARM INC90 citations98
US5902817AMay 11, 1999
Certain sulfoxide and sulfone derivatives
GUILFORD PHARM INC104 citations98
US5863536AJan 26, 1999
Phosphoramidate derivatives
GUILFORD PHARM INC121 citations98
US5795877AAug 18, 1998
Inhibitors of NAALADase enzyme activity
GUILFORD PHARM INC143 citations98
US5672592ASep 30, 1997
Certain phosphonomethyl-pentanedioic acid derivatives thereof
GUILFORD PHARM INC100 citations98
US6395718B1May 28, 2002
Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
GUILFORD PHARM INC132 citations97
US6265609B1Jul 24, 2001
Thio-substituted pentanedioic acid derivatives
GUILFORD PHARM INC66 citations96
US6071965AJun 6, 2000
Phosphinic alkanoic acid derivatives
GUILFORD PHARM INC58 citations96
US6054444AApr 25, 2000
Phosphonic acid derivatives
GUILFORD PHARM INC83 citations96
US6046180AApr 4, 2000
NAALADase inhibitors
GUILFORD PHARM INC79 citations96
US6025344AFeb 15, 2000
Certain dioic acid derivatives useful as NAALADase inhibitors
GUILFORD PHARM INC45 citations96
US6011021AJan 4, 2000
Methods of cancer treatment using naaladase inhibitors
GUILFORD PHARM INC51 citations96
US6004946ADec 21, 1999
Treatment of global and focal ischemia using naaladase inhibitors
GUILFORD PHARM INC39 citations96
US5977090ANov 2, 1999
Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
GUILFORD PHARM INC79 citations96
US5880112AMar 9, 1999
Naaladase inhibitors
GUILFORD PHARM INC86 citations96
US5824662AOct 20, 1998
Treatment of global and focal ischemia using naaladase inhibitors
GUILFORD PHARM INC74 citations96
US5804602ASep 8, 1998
Methods of cancer treatment using naaladase inhibitors
GUILFORD PHARM INC90 citations96
US6479471B1Nov 12, 2002
NAALADase inhibitors
GUILFORD PHARM INC21 citations93
US6452044B2Sep 17, 2002
Benzenedicarboxylic acid derivatives
GUILFORD PHARM INC28 citations93
US6413948B1Jul 2, 2002
Pharmaceutical compositions and methods of effecting a neuronal activity in an animal using naaladase inhibitors
GUILFORD PHARM INC29 citations93
US6372726B1Apr 16, 2002
Methods of cancer treatment using NAALADase inhibitors
GUILFORD PHARM INC35 citations93
US6348464B1Feb 19, 2002
Pyrrolecarbonylimino derivatives as naaladase inhibitors
GUILFORD PHARM INC35 citations93
US6313159B1Nov 6, 2001
Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
GUILFORD PHARM INC39 citations93
US6288046B1Sep 11, 2001
Phosphonic acid derivatives
GUILFORD PHARM INC35 citations93
US6271245B1Aug 7, 2001
Hydroxamic acid derivatives
GUILFORD PHARM INC37 citations93
US6228888B1May 8, 2001
Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors
GUILFORD PHARM INC26 citations93
US6025345AFeb 15, 2000
Inhibitors of NAALADase enzyme activity
GUILFORD PHARM INC46 citations93
US5985855ANov 16, 1999
Treatment of global and focal ischemia using NAALADase inhibitors
GUILFORD PHARM INC29 citations93
US6586623B2Jul 1, 2003
Thiol-based NAALADase inhibitors
GUILFORD PHARM INC25 citations92
US6458775B1Oct 1, 2002
NAALADase inhibitors useful as pharmaceutical compounds and compositions
GUILFORD PHARM INC30 citations92
US6121252ASep 19, 2000
Phosphinic acid derivatives
GUILFORD PHARM INC34 citations90
US6444657B1Sep 3, 2002
Methods for treating certain diseases using naaladase inhibitors
GUILFORD PHARM INC31 citations89
US5981209ANov 9, 1999
Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
GUILFORD PHARM INC46 citations89
US6812364B2Nov 2, 2004
Thiol-based NAALADase inhibitors
GUILFORD PHARM INC8 citations74
US6376478B1Apr 23, 2002
Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors
GUILFORD PHARM INC10 citations74
US7220780B2May 22, 2007
Naaladase inhibitors for treating retinal disorders and glaucoma
GUILFORD PHARM INC9 citations71
US7125907B2Oct 24, 2006
Thiolactones
GUILFORD PHARM INC4 citations63
US5925666AJul 20, 1999
Pharmaceutical compositions and methods for treating compulsive disorders using pyrrolidine derivatives
GUILFORD PHARM INC2 citations63
US6806261B2Oct 19, 2004
Methods for treating certain diseases using naaladase inhibitors
GUILFORD PHARM INC1 citations59
US6992215B2Jan 31, 2006
Thiol-based NAALADase inhibitors
GUILFORD PHARM INC0 citations52
US6852750B2Feb 8, 2005
Benzenedicarboxylic acid derivatives
GUILFORD PHARM INC1 citations52
UNIV JOHNS HOPKINS
3 patentsUS11191732B2Dec 7, 2021
Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy
UNIV JOHNS HOPKINS0 citations59
US10660861B2May 26, 2020
Glutaminase inhibitor discovery and nanoparticle-enhanced delivery for cancer therapy
UNIV JOHNS HOPKINS0 citations49
US8778688B2Jul 15, 2014
High-throughput methods for determining pharmacological levels of plasma D-serine
UNIV JOHNS HOPKINS0 citations36
ZACK DONALD J
1 patentEISAI CORP NORTH AMERICA
1 patentEISAI INC
1 patentShowing the top 50 of 52 patents by PatentIndex Score.